Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Gilbert

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Chemical Biology|July 21, 2014
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitorsBryan R Lanning, Landon R Whitby, Melissa M Dix, et al.
Journal of Medicinal Chemistry|February 18, 2014
1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulatorsEugene L Piatnitski Chekler, Rayomond Unwalla, Taukeer A Khan, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Intramolecular Ring-Opening Decomposition of Aryl AzetidinesGuoyun Bai, Thomas N O'Connell, Michael A Brodney, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Hit to lead studies on (hetero)arylpyrimidines--agonists of the canonical Wnt-beta-catenin cellular messaging systemAdam M Gilbert, Matthew G Bursavich, Nippa Alon, et al.
Journal of Medicinal Chemistry|February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in HumansAtli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
Journal of Medicinal Chemistry|March 3, 2018
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of NeuroinflammationLaura A McAllister, Christopher R Butler, Scot Mente, et al.
ACS Chemical Biology|July 9, 2016
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in MetabolismKay Ahn, Markus Boehm, Matthew F Brown, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Chemical Biology|July 21, 2014
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitorsBryan R Lanning, Landon R Whitby, Melissa M Dix, et al.
Journal of Medicinal Chemistry|February 18, 2014
1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulatorsEugene L Piatnitski Chekler, Rayomond Unwalla, Taukeer A Khan, et al.
ACS Medicinal Chemistry Letters|October 22, 2021
Intramolecular Ring-Opening Decomposition of Aryl AzetidinesGuoyun Bai, Thomas N O'Connell, Michael A Brodney, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Hit to lead studies on (hetero)arylpyrimidines--agonists of the canonical Wnt-beta-catenin cellular messaging systemAdam M Gilbert, Matthew G Bursavich, Nippa Alon, et al.
Journal of Medicinal Chemistry|February 1, 2017
Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in HumansAtli Thorarensen, Martin E Dowty, Mary Ellen Banker, et al.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
Journal of Medicinal Chemistry|March 3, 2018
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of NeuroinflammationLaura A McAllister, Christopher R Butler, Scot Mente, et al.
ACS Chemical Biology|July 9, 2016
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in MetabolismKay Ahn, Markus Boehm, Matthew F Brown, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
ACS Chemical Biology|October 30, 2016
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective InhibitionJean-Baptiste Telliez, Martin E Dowty, Lu Wang, et al.
Pageof 5